BIOMAT Database Logo BIOMAT Database Logo

Crystal structure of Escherichia coli purine nucleoside phosphorylase complexed with acyclovir. 2018

Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Shubnikov Institute of Crystallography, Federal Scientific Research Centre `Crystallography and Photonics' of Russian Academy of Sciences, Leninsky Prospekt 59, Moscow 119333, Russian Federation.

Escherichia coli purine nucleoside phosphorylase (PNP), which catalyzes the reversible phosphorolysis of purine ribonucleosides, belongs to the family I hexameric PNPs. Owing to their key role in the purine salvage pathway, PNPs are attractive targets for drug design against some pathogens. Acyclovir (ACV) is an acyclic derivative of the PNP substrate guanosine and is used as an antiviral drug for the treatment of some human viral infections. The crystalline complex of E. coli PNP with acyclovir was prepared by co-crystallization in microgravity using counter-diffusion through a gel layer in a capillary. The structure of the E. coli PNP-ACV complex was solved at 2.32 Å resolution using the molecular-replacement method. The ACV molecule is observed in two conformations and sulfate ions were located in both the nucleoside-binding and phosphate-binding pockets of the enzyme. A comparison with the complexes of other hexameric and trimeric PNPs with ACV shows the similarity in acyclovir binding by these enzymes.

UI MeSH Term Description Entries
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D029968 Escherichia coli Proteins Proteins obtained from ESCHERICHIA COLI. E coli Proteins

Related Publications

Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure of human purine nucleoside phosphorylase complexed with acyclovir.
August 2003, Biochemical and biophysical research communications,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
New phosphate binding sites in the crystal structure of Escherichia coli purine nucleoside phosphorylase complexed with phosphate and formycin A.
April 2012, FEBS letters,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure of Schistosoma purine nucleoside phosphorylase complexed with a novel monocyclic inhibitor.
May 2010, Acta tropica,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure of calf spleen purine nucleoside phosphorylase complexed to a novel purine analogue.
October 2007, FEBS letters,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure and molecular dynamics studies of human purine nucleoside phosphorylase complexed with 7-deazaguanine.
March 2010, Journal of structural biology,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure and molecular dynamics studies of purine nucleoside phosphorylase from Mycobacterium tuberculosis associated with acyclovir.
January 2012, Biochimie,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure of purine nucleoside phosphorylase from Thermus thermophilus.
April 2004, Journal of molecular biology,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
The crystal structure of Escherichia coli purine nucleoside phosphorylase: a comparison with the human enzyme reveals a conserved topology.
October 1997, Structure (London, England : 1993),
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Crystal structure of human purine nucleoside phosphorylase at 2.3A resolution.
August 2003, Biochemical and biophysical research communications,
Vladimir I Timofeev, and Nadezhda E Zhukhlistova, and Yuliya A Abramchik, and Tatiana I Muravieva, and Roman S Esipov, and Inna P Kuranova
Properties of a mutant of Escherichia coli lacking purine nucleoside phosphorylase.
July 1968, Biochimica et biophysica acta,
Copied contents to your clipboard!